Deidre Roniger serves as Senior Vice President of Corporate Development at Ambys Medicines, Ms. Roniger brings more than 20 years of biotech corporate strategy, business development, marketing and business analytics experience to Ambys. Most recently, she served as Managing Partner at DNA Ink, a boutique life sciences consulting firm offering corporate advisory and transaction services for biotech, medtech and pharma clients. Ms. Roniger’s previous experience includes nearly a decade at Genentech, where she held roles of increasing responsibility. Most recently, she served as Director, Market Analysis & Strategy, where she led a team of more than 100 full-time analytics professionals responsible for identifying critical business issues and opportunities for growth, informing the strategic direction of Genentech. In this role, Ms. Roniger was accountable for the management of all primary market research, forecasting and business analytics across Genentech’s portfolio. Previously, Ms. Roniger held a variety of operational and leadership roles across Genentech’s commercial organization. Ms. Roniger earned a BS in Biochemistry and Molecular Biology from the University of California, San Diego, and an MBA from Wake Forest University’s Babcock Graduate School of Management.
